clinical trial · NCT03336216
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
Bristol-Myers Squibb·phase2·completed·n = 205
Advanced Pancreatic CancerCabiralizumabNab-paclitaxelOnivydeNivolumabFluorouracilGemcitabineOxaliplatinLeucovorin
brief summary
The purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without chemotherapy, is effective for the treatment of advanced pancreatic cancer.
started
Dec 18, 2017
primary completion
Jun 1, 2023
completion
Jun 1, 2023
last updated
Jul 23, 2024
official title
A Phase 2 Study of Cabiralizumab (BMS-986227, FPA008) Administered in Combination With Nivolumab (BMS-936558) With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol